TTEN·K/calls
Pinned
  • The Brief
  • Congress
  • Screener
  • Markets
  • The Brief
  • Signal Confluence
  • The Flip Side
  • Markets
  • Calendar
  • Coverage
  • Screener
  • Discover
  • Smart Money
  • Congress
  • Insiders
  • IPOs
  • ETF Holdings
  • 13F Funds
  • Events
  • Filings
  • News
  • Trending
  • Groups
  • Data catalog
  • Research
  • Education
  • Options Plays
  • Options Calculator
  • Leaderboards
  • Compare
  • Portfolio
  • Strategies
  • Track
  • Pricing
  • API
  • Newsletter
  • Follow the calls
  • Feedback
  • Account
Go ProUpgrade →
TTEN·K/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Telegram ↗X ↗Bluesky ↗Follow the calls →

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

MethodologyDisclosuresTermsPrivacy

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

← New search
Home›Coverage›DXR
On this page
OverviewFinancialsValuationQualitySmart moneyTimelineFilings
DXR logo

DXRDAXOR CORP

Avoid
$10.53
▲ +4.15%
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Clean
How to read this →
AvoidRevenue declined -8.4% YoY.Revenue (FY2011) $1.45MFull call ↓
$10.53▲ +6.80%
over 1Y
L $8.87H $14.75
Our buy Our hold Our sell Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today
+4.2%
1W
+0.0%
1M
+7.9%
3M
+11.2%
YTD
-26.7%
1Y
+6.8%
OverviewFinancialsValuationQualitySmart moneyTimelineFilings
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Buy

Revenue declined -8.4% YoY.

Revenue (FY2011) $1.45M · FY2011

This call stands until the filings change it — the engine re-rates on new 10-K/10-Q/8-K facts, never on price moves. Hit Watch above to follow DXR (Pro alerts fire the moment a rating flips), or catch every change in Saturday’s Flip Side. How to read a call

DAXOR CORP shows $1.45M in FY2011 revenue (-8.4% YoY), a -496.8% net margin, and -19.8% ROE.

Weighing against it: revenue declined -8.4% YoY; unprofitable (net margin -496.8%).

Is DXR a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread (caution)~60d expiry
  • Long put 10.5 @ ~0.89 est
  • Short put 9.5 @ ~0.45 est
debit $44max +$56max −$44BE 10.06

AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.

Open in the calculator →
Browse all model plays →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financialsannual, by fiscal year

Line itemFY10FY11
Revenue$1.58M$1.45M
Gross profit$852K$794K
Operating income-$5.66M-$5.79M
Net income$4.97M-$7.19M
Diluted EPS$1.17-$1.70
Net margin314.6%-496.8%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$61.4M
EV / EBITDA—
EV / Sales42.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-11.7%
FCF yield-10.8%

Quality & risk

ROIC (est.)-12.6%
Free cash flow-$6.63M
Total debt—
Net cash$59.6K
Altman Z-Score1.40 distress
Piotroski F-Score2/7

Capital returns

Buyback yield—
Dividend yield (est.)1.7%
Shareholder yield1.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timelineSEC · 8-Ks + reports

Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Shareholder vote2026-06-24
  2. DEF 14A Proxy statement2026-06-03
  3. 8-K Material agreement2026-01-26
  4. 8-K Other event2026-01-23
  5. 8-K Other event2025-08-07
  6. 8-K Shareholder vote2025-07-01
  7. DEF 14A Proxy statement2025-06-06
  8. 8-K Shareholder vote2024-07-18
  9. DEF 14A Proxy statement2024-06-21

Recent filings

all on EDGAR ↗
4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗8-KPeriod ending 2026-06-232026-06-24open ↗40-8F-2/AFiling2026-06-17open ↗DEF 14APeriod ending 2026-06-032026-06-03open ↗NT NPORT-PPeriod ending 2026-03-312026-06-02open ↗40-8F-2/AFiling2026-05-21open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthF
ProfitabilityF
Financial healthC+
MomentumD
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
8.8752-week14.75
Revenue
$1.45M
-8.4% YoY
Net margin
-496.8%
ROE
-19.8%
P/E
—

SEC fundamentals · FY 2011

'10'11

■ revenue · ■ net income, by fiscal year

Revenue$1.45M-8.4%
Net income-$7.19M-244.6%
Gross profit$794K-6.8%
Operating income-$5.79M-2.2%
Diluted EPS-$1.70-245.3%
Cash & equivalents$59.6K+3.3%
Total assets$85.7M-6.0%
Total liabilities$49.5M+12.0%
Stockholders' equity$36.2M-22.9%
Gross: 54.9%Op.: -400.1%L/E: 1.37x

Frequently asked

Is DAXOR CORP (DXR) a buy?
DXR currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue declined -8.4% YoY.
What is DAXOR CORP's quality score?
DXR scores 32.97060991813467/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

New filings change verdicts

The daily Brief delivers our freshest calls, rating flips and the filings behind them — every morning, free.

Sources: SEC EDGAR (CIK 0000027367, latest 10-K filed 2012-03-28) · EODHD · as of 7/12/2026, 12:08:10 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 12, 2026, 8:08 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%BRK-A$739,750.00▼0.17%BRK-B$493.71▼0.35%LLY$1,188.58▼2.33%AMD$557.89▲2.04%WMT$113.90▲1.51%JPM$336.47▲0.30%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%CAT$952.41▲1.49%ABBV$248.08▼0.73%LRCX$350.33▼0.80%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%BRK-A$739,750.00▼0.17%BRK-B$493.71▼0.35%LLY$1,188.58▼2.33%AMD$557.89▲2.04%WMT$113.90▲1.51%JPM$336.47▲0.30%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%CAT$952.41▲1.49%ABBV$248.08▼0.73%LRCX$350.33▼0.80%BAC$59.67▲0.71%
Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%BRK-A$739,750.00▼0.17%BRK-B$493.71▼0.35%LLY$1,188.58▼2.33%AMD$557.89▲2.04%WMT$113.90▲1.51%JPM$336.47▲0.30%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%CAT$952.41▲1.49%ABBV$248.08▼0.73%LRCX$350.33▼0.80%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%BRK-A$739,750.00▼0.17%BRK-B$493.71▼0.35%LLY$1,188.58▼2.33%AMD$557.89▲2.04%WMT$113.90▲1.51%JPM$336.47▲0.30%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%CAT$952.41▲1.49%ABBV$248.08▼0.73%LRCX$350.33▼0.80%BAC$59.67▲0.71%

Insider activityForm 4 · SEC

all insiders →
2026-06-23
Michel Robert J
Chief Financial Officer
Award
12.0K
2026-06-23
Feldschuh Michael Richard
Chief Executive Officer
Award
30.0K
2026-06-23
Feldschuh Jonathan Adam
Chief Scientific Officer
Award
25.0K
2026-04-08
Feldschuh Michael Richard
Chief Executive Officer
Buy
1.00K @ $9.07$9.07K

ETF ownershipForm N-PORT · SEC · quarterly

VTIVanguard Total Stock Market ETF0.00%$469K

Weight = the ETF’s percent of assets in DXR, as of each fund’s latest public N-PORT (period end 2026-03-31) — a delayed, roughly quarterly snapshot filed ~2 months after the period, not a live position.

Fails-to-deliver

SEC · settled 2026-06-12

No unusual settlement fails — 199 shares failed to deliver on the latest published day.

DXR fails-to-deliver history — every published settlement day →

Aggregate CNS settlement fails on the latest published day, vs this name’s trailing median. From SEC fails-to-deliver data (published twice monthly) — a settlement metric, not short interest.

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2018-01-05
Last amount
$0.03
ex 2018-01-05paid 2018-01-12$0.03
ex 2017-12-20$0.03
ex 2016-12-20paid 2016-12-29$0.03
ex 2015-12-18paid 2015-12-29$0.04
ex 2014-12-04paid 2014-12-26$0.03
ex 2013-12-05paid 2013-12-27$0.05

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Recent news

market news →
Dynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF SeriesBullish
finance.yahoo.com· 2026-04-20
Dynamic announces March 2026 cash distributions for Dynamic Active ETFs and ETF SeriesBullish
finance.yahoo.com· 2026-03-19
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth SummitBullish
globenewswire.com· 2025-10-21
Dynamic Funds announces August 2025 cash distributions for Dynamic Active ETFs and ETF SeriesBullish
finance.yahoo.com· 2025-08-19
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis SystemBullish
globenewswire.com· 2025-08-07
Florida Healthcare Leader Embraces Daxor Blood Volume Analysis TechnologyBullish
globenewswire.com· 2025-05-07

Vs tracked universe

compare →

1180 tracked peers · median

TENK Score33 vs 67
Revenue growth-8.4% vs 7.6%
Net margin-496.8% vs 10.1%
Return on equity-19.8% vs 12.0%
P/E— vs 26.5